Summit Therapeutics Inc.
SMMT
Revenue
0.00
0.000.00%
12 Months ChangeAssets
71.79M
▼-1.33M▼-1.82%
3 Months ChangeLiabilities
17.26M
▲3.36M▲24.17%
3 Months ChangeFree Cash Flow
-30.14M
▼-16.95M▼-128.60%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 10-Q
ID: 0001599298-24-000158
2024-10-30
Form 8-K
ID: 0001599298-24-000156
2024-09-12
Form 8-K
ID: 0001193125-24-217618
2024-09-09
Form 8-K
ID: 0001599298-24-000128
2024-08-06
Form 10-Q
ID: 0001599298-24-000117
2024-08-06
Form 8-K
ID: 0001599298-24-000113
2024-06-27
Form 8-K
ID: 0001599298-24-000103
2024-06-17
Form 8-K
ID: 0001193125-24-162715
2024-06-03
Form 8-K
ID: 0001193125-24-152309
2024-06-03
Form 8-K
ID: 0001193125-24-152292